A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
Clinical trial NCT01160861 · COMPLETED
Trial details
- NCT number
- NCT01160861
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-11
- Primary completion
- 2011-04-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.